Director/PDMR Shareholding

Summary by AI BETAClose X

Nicola Blackwood, a non-executive director of RTW Biotech Opportunities Ltd, has disclosed the purchase of an aggregate of 23,373 ordinary shares during the fourth quarter of 2025. These transactions, which occurred on October 6, 2025, and December 23, 2025, on the London Stock Exchange, were initially omitted from public disclosure due to an oversight but have since been rectified. The shares were acquired at an average price of $1.7439, with individual purchase prices ranging from $1.5585 to $2.18844.

Disclaimer*

RTW Biotech Opportunities Ltd
22 January 2026
 

RTW BIOTECH OPPORTUNITIES LTD

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

The Company announces that Nicola Blackwood, non-executive director, purchased an aggregate of 23,373 shares in the fourth quarter of 2025. Due to an oversight these purchases were not notified to the Company and therefore not disclosed publicly. As soon as this oversight was identified the situation was rectified immediately Details of the purchases are set out below.

 

1

Details of the person discharging managerial responsibilities / person closely associated 

a)

Name

Nicola Blackwood

 

2

Reason for the notification

 

a)

Position/status

 

Director

b)

 

Initial notification /Amendment

Initial notification

 

 

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

RTW Biotech Opportunities Ltd 

b)

LEI

549300Q7EXQQH6KF7Z84

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of no par value 

 

 

 

 

GG00BKTRRM22

b)

Nature of the transaction

Purchase of Shares

c)

Price(s) and volume(s)

 Price(s)

Volume(s)

 $1.5585

$2.18844

16,493

6,880

 

d)

Aggregated information

- Aggregated volume

- Price

 

 

23,373

 

$1.7439

 

e)

Date of the transaction

6 October 2025 and 23 December 2025

 

f)

Place of the transaction

London Stock Exchange

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings